{"transactions":[{"id":3928731,"issuer":{"id":8401,"kind":"organization","name":"CURIS INC"},"owners":[{"id":166581,"kind":"person","name":"Tuck David","position":1,"cik":"0001664707","reported_name":"Tuck David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2018-05-17T20:11:44.000Z","date":"2018-05-15","kind":"grant","acquired":true,"shares":535000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option grant, as disclosed in Curis Inc.'s 2018 proxy statement, was approved by the Compensation Committee of the Board of Directors of Curis, Inc. on January 22, 2018, contingent upon shareholder approval of Curis's Third Amended and Restated 2010 Stock Incentive Plan to increase the number of shares authorized for issuance thereunder; and further provided that such option would not be exercisable and no common stock would be issued thereunder, if the Third Amended and Restated 2010 Plan was not approved by Curis's shareholders. On May 15, 2018, at the 2018 annual meeting of shareholders, Curis's shareholders approved the Third Amended and Restated 2010 Plan. The option grant described in this Form 4 filing vests as to 25% of the original shares on January 22, 2019 and as to an additional 6.25% of the original shares each successive quarter and until January 22, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant, as disclosed in Curis Inc.'s 2018 proxy statement, was approved by the Compensation Committee of the Board of Directors of Curis, Inc. on January 22, 2018, contingent upon shareholder approval of Curis's Third Amended and Restated 2010 Stock Incentive Plan to increase the number of shares authorized for issuance thereunder; and further provided that such option would not be exercisable and no common stock would be issued thereunder, if the Third Amended and Restated 2010 Plan was not approved by Curis's shareholders. On May 15, 2018, at the 2018 annual meeting of shareholders, Curis's shareholders approved the Third Amended and Restated 2010 Plan. The option grant described in this Form 4 filing vests as to 25% of the original shares on January 22, 2019 and as to an additional 6.25% of the original shares each successive quarter and until January 22, 2022."}],"balance_after":535000,"derivative":{"exercise_price":0.69,"expiration_date":"2028-01-21","underlying":"Common stock","underlying_shares":535000},"source":{"system":"sec-edgar","filing":"0001209191-18-030875","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1108205/000120919118030875/doc4.xml","form_type":"4"}},{"id":4091246,"issuer":{"id":8401,"kind":"organization","name":"CURIS INC"},"owners":[{"id":166581,"kind":"person","name":"Tuck David","position":1,"cik":"0001664707","reported_name":"Tuck David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common stock","published_at":"2018-01-24T21:39:52.000Z","date":"2018-01-22","kind":"grant","acquired":true,"shares":133750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award is in the form of restricted common stock. The award vests as to 25% of the underlying shares on the first anniversary of the date of grant and as to an additional 25% of the underlying shares annually thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents 35,674 shares of unrestricted common stock acquired under Curis, Inc.'s Amended and Restated 2010 Employee Stock Purchase Plan and 133,750 shares of restricted common stock."}],"balance_after":169424,"source":{"system":"sec-edgar","filing":"0001209191-18-005142","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1108205/000120919118005142/doc4.xml","form_type":"4"}},{"id":4443107,"issuer":{"id":8401,"kind":"organization","name":"CURIS INC"},"owners":[{"id":166581,"kind":"person","name":"Tuck David","position":1,"cik":"0001664707","reported_name":"Tuck David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2017-02-16T21:35:53.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":534000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 25% of the shares on January 1, 2018 and as to an additional 6.25% of the original shares each successive three month period through and until January 1, 2021."}],"balance_after":534000,"derivative":{"exercise_price":2.63,"expiration_date":"2027-02-13","underlying":"Common stock","underlying_shares":534000},"source":{"system":"sec-edgar","filing":"0001209191-17-011476","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1108205/000120919117011476/doc4.xml","form_type":"4"}}]}